Rapid Assessment of Zika Virus (ZIKV) Complications (R21)

Funding Opportunity Number: PAR-16-106 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: HealthIncome Security and Social ServicesCFDA Number: 93.12193.28693.83993.85393.85593.85693.86593.867Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationPrivate institutions of higher educationFor profit organizations other than small businessesSmall businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-NIH11Closing Date: Apr 30, 2019Award Ceiling: $200,000Expected Number of Awards: Creation Date: Feb 19, 2016Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited (rapid) funding mechanism for research on Zika virus (ZIKV) and its complications.ZIKV is a single-stranded RNA virus of the Flaviviridae family. It is transmitted to humans primarily ...
Source: Grants.gov - Category: Research Tags: Health Income Security and Social Services Source Type: funding